312 related articles for article (PubMed ID: 34952913)
1. The value of lateral flow urine lipoarabinomannan assay and empirical treatment in Xpert MTB/RIF ultra negative patients with presumptive TB: a prospective cohort study.
Kebede W; Abebe G; Gudina EK; Van Rie A
Sci Rep; 2021 Dec; 11(1):24428. PubMed ID: 34952913
[TBL] [Abstract][Full Text] [Related]
2. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.
Orlando S; Triulzi I; Ciccacci F; Palla I; Palombi L; Marazzi MC; Giuliano M; Floridia M; Mancinelli S; Mutemba E; Turchetti G
PLoS One; 2018; 13(7):e0200523. PubMed ID: 30024890
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohort.
Lawn SD; Kerkhoff AD; Burton R; Schutz C; Boulle A; Vogt M; Gupta-Wright A; Nicol MP; Meintjes G
BMC Med; 2017 Mar; 15(1):67. PubMed ID: 28320384
[TBL] [Abstract][Full Text] [Related]
4. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.
Shah M; Hanrahan C; Wang ZY; Dendukuri N; Lawn SD; Denkinger CM; Steingart KR
Cochrane Database Syst Rev; 2016 May; 2016(5):CD011420. PubMed ID: 27163343
[TBL] [Abstract][Full Text] [Related]
5. Incremental yield and cost of urine Determine TB-LAM and sputum induction in seriously ill adults with HIV.
Boyles TH; Griesel R; Stewart A; Mendelson M; Maartens G
Int J Infect Dis; 2018 Oct; 75():67-73. PubMed ID: 30125689
[TBL] [Abstract][Full Text] [Related]
6. Impact of diagnostic strategies for tuberculosis using lateral flow urine lipoarabinomannan assay in people living with HIV.
Nathavitharana RR; Lederer P; Chaplin M; Bjerrum S; Steingart KR; Shah M
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014641. PubMed ID: 34416013
[TBL] [Abstract][Full Text] [Related]
7. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
Peter J; Theron G; Chanda D; Clowes P; Rachow A; Lesosky M; Hoelscher M; Mwaba P; Pym A; Dheda K;
BMC Infect Dis; 2015 Jul; 15():262. PubMed ID: 26156025
[TBL] [Abstract][Full Text] [Related]
8. The New Xpert MTB/RIF Ultra: Improving Detection of
Chakravorty S; Simmons AM; Rowneki M; Parmar H; Cao Y; Ryan J; Banada PP; Deshpande S; Shenai S; Gall A; Glass J; Krieswirth B; Schumacher SG; Nabeta P; Tukvadze N; Rodrigues C; Skrahina A; Tagliani E; Cirillo DM; Davidow A; Denkinger CM; Persing D; Kwiatkowski R; Jones M; Alland D
mBio; 2017 Aug; 8(4):. PubMed ID: 28851844
[TBL] [Abstract][Full Text] [Related]
9. Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture.
Balcha TT; Sturegård E; Winqvist N; Skogmar S; Reepalu A; Jemal ZH; Tibesso G; Schön T; Björkman P
PLoS One; 2014; 9(1):e85478. PubMed ID: 24465572
[TBL] [Abstract][Full Text] [Related]
10. Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective, cross-sectional, diagnostic accuracy study.
Reeve BWP; Ndlangalavu G; Mishra H; Palmer Z; Tshivhula H; Rockman L; Naidoo S; Mbu DL; Naidoo CC; Derendinger B; Walzl G; Malherbe ST; van Helden PD; Semitala FC; Yoon C; Gupta RK; Noursadeghi M; Warren RM; Theron G
Lancet Glob Health; 2024 May; 12(5):e793-e803. PubMed ID: 38583458
[TBL] [Abstract][Full Text] [Related]
11. Role of empiric treatment in hospitalized patients with Xpert MTB/RIF-negative presumptive pulmonary tuberculosis: A prospective cohort study.
Kebede W; Abebe G; Gudina EK; De Vos E; Riviere E; Van Rie A
Int J Infect Dis; 2020 Aug; 97():30-37. PubMed ID: 32526390
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarce.
Peter JG; Theron G; Muchinga TE; Govender U; Dheda K
PLoS One; 2012; 7(7):e39966. PubMed ID: 22815718
[TBL] [Abstract][Full Text] [Related]
13. Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective diagnostic accuracy study.
Reeve BW; Ndlangalavu G; Mishra H; Palmer Z; Tshivhula H; Rockman L; Naidoo S; Mbu DL; Naidoo CC; Derendinger B; Walzl G; Malherbe ST; van Helden PD; Semitala FC; Yoon C; Gupta RK; Noursadeghi M; Warren RM; Theron G
medRxiv; 2023 Jun; ():. PubMed ID: 37333303
[TBL] [Abstract][Full Text] [Related]
14. Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individuals.
Shah M; Ssengooba W; Armstrong D; Nakiyingi L; Holshouser M; Ellner JJ; Joloba M; Manabe YC; Dorman SE
AIDS; 2014 Jun; 28(9):1307-14. PubMed ID: 24637544
[TBL] [Abstract][Full Text] [Related]
15. Xpert MTB/RIF diagnosis of childhood tuberculosis from sputum and stool samples in a high TB-HIV-prevalent setting.
Orikiriza P; Nansumba M; Nyehangane D; Bastard M; Mugisha IT; Nansera D; Mwanga-Amumpaire J; Boum Y; Kumbakumba E; Bonnet M
Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1465-1473. PubMed ID: 29740714
[TBL] [Abstract][Full Text] [Related]
16. Combination of Xpert® MTB/RIF and DetermineTM TB-LAM Ag improves the diagnosis of extrapulmonary tuberculosis at Jimma University Medical Center, Oromia, Ethiopia.
Simieneh A; Tadesse M; Kebede W; Gashaw M; Abebe G
PLoS One; 2022; 17(2):e0263172. PubMed ID: 35113917
[TBL] [Abstract][Full Text] [Related]
17. Accuracy and incremental yield of urine Xpert MTB/RIF Ultra versus Determine TB-LAM for diagnosis of pulmonary tuberculosis.
Andama A; Jaganath D; Crowder R; Asege L; Nakaye M; Katumba D; Mwebe S; Semitala F; Worodria W; Joloba M; Mohanty S; Somoskovi A; Cattamanchi A
Diagn Microbiol Infect Dis; 2020 Jan; 96(1):114892. PubMed ID: 31727376
[TBL] [Abstract][Full Text] [Related]
18. Impact of Xpert MTB/RIF in the Diagnosis of Childhood Tuberculosis in Rural Ethiopia.
Pérez-Butragueño M; Ramos-Rincón JM; Tesfamariam A; Comeche B; Mohammed N; Tiziano G; Endirays J; Biru D; Elala T; Edri A; Prieto L; Górgolas M
J Trop Pediatr; 2022 Jun; 68(4):. PubMed ID: 35848941
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Xpert MTB/RIF Ultra performance for pulmonary tuberculosis diagnosis on smear-negative respiratory samples in a French centre.
Hodille E; Maisson A; Charlet L; Bauduin C; Genestet C; Fredenucci I; Rasigade JP; Lina G; Dumitrescu O
Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):601-605. PubMed ID: 30680567
[TBL] [Abstract][Full Text] [Related]
20. An Optimal Diagnostic Strategy for Tuberculosis in Hospitalized HIV-Infected Patients Using GeneXpert MTB/RIF and Alere Determine TB LAM Ag.
Esmail A; Pooran A; Sabur NF; Fadul M; Brar MS; Oelofse S; Tomasicchio M; Dheda K
J Clin Microbiol; 2020 Sep; 58(10):. PubMed ID: 32727831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
